Evidence map›Paper›PMID 37848569›Full record

ArticleMedical oncology (Northwood, London, England)2023

Tamoxifen induces eryptosis through calcium accumulation and oxidative stress.

Mohammad A Alfhili, Abdulaziz M Alyousef, Jawaher Alsughayyir

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. A Hypothesized Therapeutic Role of (Z)-Endoxifen in Duchenne Muscular Dystrophy (DMD).Degenerative neurological and neuromuscular disease · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mohammad A AlfhiliChair of Medical and Molecular Genetics Research, Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, 12372, Riyadh, Saudi Arabia. malfeehily@ksu.edu.sa.ORCID http://orcid.org/0000-0002-3095-9154
Abdulaziz M AlyousefChair of Medical and Molecular Genetics Research, Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, 12372, Riyadh, Saudi Arabia.
Jawaher AlsughayyirDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, 12372, Riyadh, Saudi Arabia.
King Saud University · SAKing Saud Medical City · SA

Funding

Deputyship for Research and Innovation, Ministry of Education, Saudi Arabia IFKSURC-1-4407
6 · The paper itself

Abstract

Chemotherapy-related anemia is a major obstacle in anticancer therapy. Tamoxifen (TAM) is an antiestrogen prescribed for breast cancer patients with hemolytic potential and apoptotic properties in nucleated cells. However, the eryptotic activity of TAM has hitherto escaped the efforts of investigators. RBCs from apparently healthy volunteers were treated with 1-50 μM of TAM for 24 h at 37 °C. Hemoglobin leakage and LDH, AST, and AChE activities were photometrically determined while K

Indexed as

EryptosisTamoxifenAscorbic AcidCalciumErythrocytesFluorescein-5-isothiocyanateHemolysisHumansOxidative StressPolyethylene GlycolsReactive Oxygen SpeciesUreaAscorbic AcidCalciumFluorescein-5-isothiocyanatepolyethylene glycol 8000Polyethylene GlycolsReactive Oxygen SpeciesTamoxifenUreaBreast cancerEryptosisHemolysisTamoxifen

Identifiers

PMID37848569
OpenAlexW4387701425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.